SHANGHAI, Nov 12 (Reuters) – China has approved Eli Lilly's weight loss pill orforglipron, the country's medicine regulator said on Thursday. (Reporting by Andrew Silver; additional reporting from
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
(Adds detail) NUSA DUA, Indonesia, Nov 12 (Reuters) - Indonesia's consumption of palm oil-based biodiesel…
By Aishwarya Venugopal and Alexandra Alper Nov 11 (Reuters) - Nvidia's board is meeting late…
Nov 12 (Reuters) - Alzinova AB: * Q3 OWN WORK CAPITALIZED AND OTHER INCOME SEK…
Pioneering Defence Innovation with Rayonix Tech and XTEND to Deliver Next-Generation Autonomous Tactical Drones for…
Nov 12 (Reuters) - SSAB AB (publ): * SIGNS NEW REVOLVING CREDIT FACILITY OF EUR…
SHANGHAI, Nov 12 (Reuters) - China has approved Eli Lilly's weight loss pill orforglipron, the country's…